Line of Credit 
Print FormatAnthem Shares Jump On Raised FY22 Outlook Boosted By Better Than Expected Q1 Results
- Anthem Inc NYSE:ANTM has reported Q1 FY22 adjusted EPS of
$8.25 , up 17.7% Y/Y, beating the consensus of$7.81 . - Operating revenue rose 18% to
$37.9 billion , slightly beating the expectations of$37.42 billion , driven by higher premium revenue due to growth in Medicaid & Medicare, MMM & Paramount acquisitions, higher premium rates, and pharmacy product revenue related to IngenioRx. - The benefit expense ratio was 86.1%, increasing 50 basis points versus the prior-year quarter.
- Operating cash flow was
$2.5 billion , or 1.4x net income, increasing$36 million when compared year-over-year. - Medical enrollment increased 7.5% Y/Y to 46.8 million members.
- Medical enrollment increased by 1.4 million lives, driven by organic growth in Commercial fee-based business, the acquisition of Paramount Advantage's Medicaid members in
Ohio , and growth in Individual Medicare Advantage enrollment. - On
April 19, 2022 , the company's board declared a second-quarter 2022 dividend of$1.28 per share, payable onJune 24, 2022 , to shareholders of record onJune 10, 2022 . - FY22 Outlook: Anthem expects FY22 adjusted EPS of more than
$28.40 versus prior guidance of$28.25 . - Price Action: ANTM shares are up 3.13% at
$533.21 during the premarket session on the last check Wednesday.
